Kenetik
Founded 2019
About Kenetik
VitaNav is a life sciences company founded in 2018 with the goal of creating the next generation of commercially viable energy and neurohealth compounds. The company’s first patent related to its development of D-beta hydroxybutyrate (D-BHB) products was granted in June 2021. Its novel composition using D-BHB has a greater efficiency, better taste, and can be produced at a significantly lower cost than existing exogenous ketone products. VitaNav’s D-BHB is made with renewable plant sugars using a proprietary carbon negative bio-fermentation process.
Company Facts
- Founded: 2019
- Legal name: VitaNav Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.7M
- Last round: Series Unknown (Feb 2026)
- Website: https://drinkkenetik.com/
- Phone: +1 650-561-5871
Social Profiles
Canonical: https://fsome.com/organization/kenetik-8304805 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.